ArticleExpert systems with applications2022
Article in Expert systems with applications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- "Good and bad investments" in public health stocks amid the COVID-19 shock: evidence from a transformer-based model.Frontiers in public health · 2025Article
- Role of proliferation COVID-19 media chatter in predicting Indian stock market: Integrated framework of nonlinear feature transformation and advanced AI.Expert systems with applications · 2023Article
- COVID19-MLSF: A multi-task learning-based stock market forecasting framework during the COVID-19 pandemic.Expert systems with applications · 2023Article
- Global prediction model for COVID-19 pandemic with the characteristics of the multiple peaks and local fluctuations.BMC medical research methodology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The novel of coronavirus (COVID-19) has suddenly and abruptly changed the world as we knew at the start of the 3rd decade of the 21st century. Particularly, COVID-19 pandemic has negatively affected financial econometrics and stock markets across the globe. Artificial Intelligence (AI) and Machine Learning (ML)-based prediction models, especially Deep Neural Network (DNN) architectures, have the potential to act as a key enabling factor to reduce the adverse effects of the COVID-19 pandemic and future possible ones on financial markets. In this regard, first, a unique COVID-19 related PRIce MOvement prediction (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.